These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 5919798)

  • 1. On intraocular fibrinolysis.
    Pandolfi M; Nilsson IM; Niléhn JE
    Thromb Diath Haemorrh; 1966 Jan; 15(1):161-72. PubMed ID: 5919798
    [No Abstract]   [Full Text] [Related]  

  • 2. On the fibrinolytic and thrombolytic properties of active-site p-anisoylated streptokinase-plasminogen complex (BRL 26921).
    Matsuo O; Collen D; Verstraete M
    Thromb Res; 1981 Nov; 24(4):347-58. PubMed ID: 7038976
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence for a sustained fibrinolytic response to anisoylated plasminogen streptokinase activator complex in vitro.
    Fears R
    Drugs; 1987; 33 Suppl 3():83-7. PubMed ID: 3315617
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison of acylated streptokinase-plasminogen complex and streptokinase in healthy volunteers.
    Prowse CV; Hornsey V; Ruckley CV; Boulton FE
    Thromb Haemost; 1982 Apr; 47(2):132-5. PubMed ID: 7048621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on fluidity of blood on the basis of fibrinolysis. 8. Analysis of fibrinolytic activity of the human blood activated with streptokinase and urokinase in vitro--with special reference to its similarity to fibrinolytic activity of fluid corpse blood.
    Ishizu H; Nobuhara M; Takata H
    Nihon Hoigaku Zasshi; 1971 Sep; 25(3):366-72. PubMed ID: 5167453
    [No Abstract]   [Full Text] [Related]  

  • 6. The evaluation of plasmin and streptokinase activator complexes in a new rabbit model of venous thrombosis.
    Dupe RJ; English PD; Smith RA; Green J
    Thromb Haemost; 1981 Aug; 46(2):528-34. PubMed ID: 6458112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inability of a highly purified streptokinase preparation to inactivate complement in serum.
    Laurell AB; Lundh B; Malmquist J
    Acta Pathol Microbiol Scand; 1965; 64(3):318-28. PubMed ID: 5855583
    [No Abstract]   [Full Text] [Related]  

  • 8. [T-PA and APSAC, new fibrinolytics].
    Med Monatsschr Pharm; 1986 Nov; 9(11):326-7. PubMed ID: 3100917
    [No Abstract]   [Full Text] [Related]  

  • 9. Fibrinolytic agents.
    Schmitz-Huebner U; van de Loo J
    Clin Haematol; 1981 Jun; 10(2):481-96. PubMed ID: 7032785
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of activation of the fibrinolytic mechanism on experimental platelet-rich thrombi in rabbits.
    Hirsh J; Buchanan M; Glynn MF; Mustard JF
    J Lab Clin Med; 1968 Aug; 72(2):245-55. PubMed ID: 5671200
    [No Abstract]   [Full Text] [Related]  

  • 11. [Thrombolytics and their use].
    Alessi MC; Juhan-Vague I
    Rev Prat; 1999 Oct; 49(15):1654-8. PubMed ID: 10581996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The thrombolytic activity of streptokinase in the rabbit.
    English PD; Smith RA; Dupe RJ; Green J; Hibbs MJ
    Thromb Haemost; 1981 Aug; 46(2):535-7. PubMed ID: 7302893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro studies of staphylokinase.
    Sweet B; McNicol GP; Douglas AS
    Clin Sci; 1965 Oct; 29(2):375-82. PubMed ID: 5840981
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the demonstration of plasmin deficiency in retracted clots of full blood and on its significance in the lysis with streptokinase].
    Gottlob R; Blümel G
    Thromb Diath Haemorrh; 1966 May; 15(3):570-90. PubMed ID: 5989036
    [No Abstract]   [Full Text] [Related]  

  • 15. [The behavior of plasmitic fibrinogenolytic and fibrinolytic activities after activation with streptokinase and urokinase].
    Ferrauto A; Cristaldi R; Terranova R; Giuffrida G
    Boll Soc Ital Biol Sper; 1965 Dec; 41(24):1483-6. PubMed ID: 5878159
    [No Abstract]   [Full Text] [Related]  

  • 16. Fibrinogen degradation products in plasma following induced hyperfibrinolysis.
    Chek JB; Panchenko NI
    East Afr Med J; 2000 Apr; 77(4):217-20. PubMed ID: 12858907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research on the mechanism of synthetic thrombolytic agents.
    Desnoyers P; Labaume J; Conard J; Samama M
    Acta Univ Carol Med Monogr; 1972; 52():33-40. PubMed ID: 4273930
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on an inhibitor of plasminogen activation in human serum.
    Hedner U
    Thromb Diath Haemorrh; 1973 Nov; 30(2):414-24. PubMed ID: 4543991
    [No Abstract]   [Full Text] [Related]  

  • 19. [On thrombolysis with various fibrinolytic agents. II. In vitro studies on intravitally-formed human blood clots].
    Schmidt HW
    Klin Wochenschr; 1966 Jun; 44(11):621-5. PubMed ID: 5987967
    [No Abstract]   [Full Text] [Related]  

  • 20. [Staphylokinase--a specific plasminogen activator].
    Rozpończyk E; Szemraj J; Malinowski M; Rozpończyk J
    Postepy Biochem; 2006; 52(1):80-6. PubMed ID: 16869305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.